1. MG
- Author
-
Stellee M P, Biscaia, Cassiano, Pires, Francislaine A R, Lívero, Daniel L, Bellan, Israel, Bini, Silvina O, Bustos, Renata O, Vasconcelos, Alexandra, Acco, Marcello, Iacomini, Elaine R, Carbonero, Martin K, Amstalden, Fábio R, Kubata, Richard D, Cummings, Marcelo, Dias-Baruffi, Fernanda F, Simas, Carolina C, Oliveira, Rilton A, Freitas, Célia Regina Cavichiolo, Franco, Roger, Chammas, and Edvaldo S, Trindade
- Subjects
Dacarbazine ,Mice ,Skin Neoplasms ,Galectin 3 ,Tumor Microenvironment ,Animals ,Antineoplastic Agents ,Neoplasm Recurrence, Local ,Ligands ,Melanoma - Abstract
Melanoma is a highly metastatic and rapidly progressing cancer, a leading cause of mortality among skin cancers. The melanoma microenvironment, formed from the activity of malignant cells on the extracellular matrix and the recruitment of immune cells, plays an active role in the development of drug resistance and tumor recurrence, which are clinical challenges in cancer treatment. These tumoral metabolic processes are affected by proteins, including Galectin-3 (Gal-3), which is extensively involved in cancer development. Previously, we characterized a partially methylated mannogalactan (MG
- Published
- 2022